A very low carbohydrate ketogenic diet prevents the progression of hepatic steatosis caused by hyperglycemia in a juvenile obese mouse model

Nutrition and Diabetes

Volumn 2, Issue NOVEMBER, 2012, Pages

  Okuda, T ^a   Morita, N ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Fatty acid; Hyperglycemia; Ketogenic diet; Ob ob mouse; Steatosis

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETYL COENZYME A CARBOXYLASE; ARACHIDONIC ACID; CHOLESTEROL; CHYLOMICRON; FATTY ACID; FATTY ACID SYNTHASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; INSULIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYOSIN HEAVY CHAIN; MYOSIN IIA; TALIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT; CONTROLLED STUDY; EXPERIMENTAL MODEL; FATTY ACID ANALYSIS; FATTY ACID SYNTHESIS; FATTY LIVER; GLUCOSE BLOOD LEVEL; HISTOLOGY; HYPERGLYCEMIA; JUVENILE; KETOGENIC DIET; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID LIVER LEVEL; LIPOGENESIS; LIQUID CHROMATOGRAPHY; LOW CARBOHYDRATE DIET; MAMMAL CELL; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

EID: 84880909307     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2012.24     Document Type: Article

References (34)

1. Kilpatrick ES, Rigby AS, Atkin SL. The Diabetes Control and Complications Trial: the gift that keeps giving. Nat Rev Endocrinol 2009; 5: 537-545.
2. Stolar M. Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010; 123: S3-S11.
3. Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes 2003; 52: 2867-2873.
4. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-778.
5. Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009; 10: 88-95.
6. Messier C, Gagnon M. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav Brain Res 1996; 75: 1-11.
7. Yang X, Ongusaha PP, Miles PD, Havstad JC, Zhang F, So WV et al. Phosphoinositide signaling links O-GlcNAc transferase to insulin resistance. Nature 2008; 451: 964-969.
8. Badman MK, Kennedy AR, Adams AC, Pissios P, Maratos-Flier E. A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independent of weight loss. Am J Physiol Endocrinol Metab 2009; 297: E1197-E1204.
9. Kennedy AR, Pissios P, Otu H, Roberson R, Xue B, Asakura K et al. A high-fat, ketogenic diet induces a unique metabolic state in mice. Am J Physiol Endocrinol Metab 2007; 292: E1724-E1739.
10. Poplawski MM, Mastaitis JW, Isoda F, Grosjean F, Zheng F, Mobbs CV. Reversal of diabetic nephropathy by a ketogenic diet. PLoS One 2011; 6: e18604.
11. Krebs P, Fan W, Chen YH, Tobita K, Downes MR, Wood MR et al. Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet. Proc Natl Acad Sci USA 2011; 108: 19678-19682.
12. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
13. Coleman DL, Hummel KP. The influence of genetic background on the expression of the obese (Ob) gene in the mouse. Diabetologia 1973; 9: 287-293.
14. Okuda T, Nakakita S, Nakayama K. Structural characterization and dynamics of globotetraosylceramide in vascular endothelial cells under TNF-Alpha stimulation. Glycoconj J 2010; 27: 287-296.
15. Morita N, Nishida T, Tanaka M, Yano Y, Okuyama H. Enhancement of polyunsaturated fatty acid production by cerulenin treatment in polyunsaturated fatty acid-roducing bacteria. Biotechnol Lett 2005; 27: 389-393.
16. Nishina PM, Lowe S, Wang J, Paigen B. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 1994; 43: 549-553.
17. Silver DL, Jiang XC, Tall AR. Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem 1999; 274: 4140-4146.
18. Miyazaki M, Kim YC, Gray-Keller MP, Attie AD, Ntambi JM. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem 2000; 275: 30132-30138.
19. Postic C, Girard J. The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 2008; 34: 643-648.
20. Jeffcoat R. Obesity-A perspective based on the biochemical interrelationship of lipids and carbohydrates. Med Hypotheses 2007; 68: 1159-1171.
21. Kasturi R, Joshi VC. Hormonal regulation of stearoyl coenzyme A desaturase activity and lipogenesis during adipose conversion of 3T3-L1 cells. J Biol Chem 1982; 257: 12224-12230.
22. Simopoulos AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med 2008; 233: 674-688.
23. Jornayvaz FR, Jurczak MJ, Lee HY, Birkenfeld AL, Frederick DW, Zhang D et al. A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain. Am J Physiol Endocrinol Metab 2010; 299: E808-E815.
24. Garbow JR, Doherty JM, Schugar RC, Travers S, Weber ML, Wentz AE et al. Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet. Am J Physiol Gastrointest Liver Physiol 2011; 300: G956-G967.
25. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002; 297: 240-243.
26. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA 2002; 99: 11482-11486.
27. Foretz M, Guichard C, Ferré P, Foufelle F. Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA 1999; 96: 12737-12742.
28. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W et al. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 2001; 98: 9116-9121.
29. Mitro N, Mak PA, Vargas L, Godio C, Hampton E, Molteni V et al. The nuclear receptor LXR is a glucose sensor. Nature 2007; 445: 219-223.
30. Bennett MK, Lopez JM, Sanchez HB, Osborne TF. Sterol regulation of fatty acid synthase promoter. coordinate feedback regulation of two major lipid pathways. J Biol Chem 1995; 270: 25578-25583.
31. Lopez JM, Bennett MK, Sanchez HB, Rosenfeld JM, Osborne TF. Sterol regulation of acetyl coenzyme A carboxylase: a mechanism for coordinate control of cellular lipid. Proc Natl Acad Sci USA 1996; 93: 1049-1053.
32. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 1996; 10: 1096-1107.
33. Dentin R, Pé gorier JP, Benhamed F, Foufelle F, Ferré P, Fauveau V et al. Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression. J Biol Chem 2004; 279: 20314-20326.
34. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 2002; 277: 11019-11025.